Mortality in the US Populations With MGUS - JAMA Network
Jul 27, 2023 · This cohort study of a nationally representative sample found that populations with MGUS had a 20% higher risk of all-cause mortality compared with the general US population without MGUS.
How Long Can a Person Live With MGUS? - Biology Insights
Aug 25, 2025 · For many individuals with MGUS, the condition does not significantly shorten life expectancy, and they live a normal lifespan without developing a more serious blood disorder.
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Jun 19, 2025 · It’s unclear how MGUS impacts a person’s life expectancy. But screenings after a MGUS diagnosis improve survival rates for people who develop multiple myeloma.
What To Eat & Avoid When You Have MGUS Or Monoclonal
Aug 2, 2023 · Regular checkup should be done to avoid multiple myeloma which significantly decreases the life expectancy of the individuals. It is now established that multiple myeloma is always preceded …
Long-term follow-up of monoclonal gammopathy of undetermined ...
Jul 10, 2018 · Bottom line: Patients with MGUS have a shorter life expectancy than the general population, and the IgM subtype is associated with a greater risk of progression at 20 years, …
How I manage monoclonal gammopathy of undetermined significance
Jan 11, 2018 · We must routinely engage our patients in an informed conversation incorporating the absolute risk of MGUS progression and comorbidity-adjusted life expectancy prior to recommending …
Mortality in the US Populations With Monoclonal Gammopathy of ...
This cohort study analyzes a nationally representative sample with a screening test for monoclonal gammopathy of undetermined significance (MGUS) to evaluate overall survival of populations with …
Guidelines recommend considering life expectancy. Patients with life expectancy < 5 years are unlikely to benefit from laboratory monitoring. For MGUS patients with long life expectancy (e.g., age < 50 …
MGUS is of clinical significance | Binding Site - Thermo Fisher Scientific
Patients diagnosed with MGUS have a significantly reduced life expectancy and a heightened mortality risk from lymphoproliferative disorders, most notably Multiple Myeloma.
Patterns of survival and causes of death following a diagnosis of ...
Our results are of importance since they give a true estimation of survival in patients with monoclonal gammopathy of undetermined significance diagnosed in clinical practice.